Profil
Alan C.
Foster is the founder of 2904357 Canada, Inc. founded in 1974.
He worked as Vice President-Pharmacology at Allergan, Inc. and Vice President-Neuroscience at Neurocrine Biosciences, Inc. He served as Chief Scientific Officer at Otonomy, Inc. from 2014 to 2022.
Dr. Foster received his undergraduate and doctorate degrees from Southampton Business School.
Anciens postes connus de Alan C. Foster
| Sociétés | Poste | Fin |
|---|---|---|
| OTONOMY | Directeur Technique/Scientifique/R&D | 15/12/2022 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
| ALLERGAN, INC. | Corporate Officer/Principal | - |
2904357 Canada, Inc.
2904357 Canada, Inc. Personnel ServicesCommercial Services Engages in supplying trained transport drivers | Fondateur | - |
Formation de Alan C. Foster
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
2904357 Canada, Inc.
2904357 Canada, Inc. Personnel ServicesCommercial Services Engages in supplying trained transport drivers | Commercial Services |
Southampton Business School
Southampton Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















